PB2100: MANAGEMENT OF RELAPSED / REFRACTORY (R/R) B-CELL NON HODGKIN LYMPHOMA (B-NHL) WITH ANTI-CD20XCD3 BISPECIFIC ANTIBODY GLOFITAMAB. A SINGLE CENTER EXPERIENCE. (23rd June 2022) - Giatra, C.; Souravla, E.; Darmani, I.; Roumelioti, A.; Kaouranis, K.; Kosmas, P.; Bampali, V.; Gardeli, D.; Papageorgiou, M.; Mellios, Z.; Karaolidou, F.; Tsonis, I.; et al.